Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€138.00

€138.00

1.920%
2.6
1.920%
€154.00
 
22:26 / Tradegate WKN: A2AR94 / Name: Shop Apotheke Europe / Stock / Software & IT Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Description Shop Apotheke Europe

Shop Apotheke Europe is a company that operates in the e-commerce sector of the pharmaceutical and healthcare industry. The company was founded in 2001 and is based in the Netherlands. It primarily focuses on the sale of prescription-free medication, beauty and personal care products, baby care products, and healthcare accessories.

Shop Apotheke Europe is an online pharmacy that allows customers to easily order their needed products from the comfort of their homes. It operates in several European countries including Germany, Austria, Switzerland, and Belgium. The company's business model is built on the provision of reliable, high-quality products at affordable prices.

Shop Apotheke Europe went public in 2016 and is currently listed on the Frankfurt Stock Exchange. The company has seen significant growth and expansion since its IPO, with revenues increasing by 37% in 2020 compared to the previous year. Shop Apotheke Europe's market capitalization is currently around 3.5 billion euros. Its growth indicates that the online pharmacy business is a promising sector to invest in.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Shop Apotheke Europe NV is only available for our menbers.
Not a member yet? Sign up for free!

Competitors of Shop Apotheke Europe

Shop Apotheke Europe's main competitors include:

1. Zur Rose Group AG - a Swiss-based online pharmacy that operates in over 20 European countries.
2. DocMorris N.V. - a Dutch online pharmacy that offers prescription and non-prescription medication, healthcare products and services.
3. Medpex - a German online pharmacy that specializes in over-the-counter medication, beauty products, and medical devices.
4. Bodyguard Apotheke - a German online pharmacy that offers a wide range of products including vitamins, supplements, and sports nutrition.
5. Apotal - a German pharmacy chain that operates both online and in brick-and-mortar stores and offers a range of OTC and prescription medications.

These companies compete with Shop Apotheke Europe in terms of pricing, product range, customer service, and delivery options. They also face similar regulatory challenges and need to comply with varying regulations in each country they operate in.

Suppliers of Shop Apotheke Europe

The most important suppliers for Shop Apotheke Europe, as a listed company in the online pharmacy industry, would likely be pharmaceutical manufacturers and distributors. These suppliers provide the medicines, medical equipment, and other healthcare products that the company sells through its online platform.

In addition, the company may also work with suppliers of packaging materials, as well as logistical partners for transportation and storage of inventory. Since Shop Apotheke Europe operates in multiple countries, suppliers that have global reach and expertise in cross-border commerce may also be important.

Overall, a strong and reliable network of suppliers is crucial for Shop Apotheke Europe's success in providing quality products and services to its customers while maintaining competitive pricing and profitability as a publicly traded company.

Financial data and news for Shop Apotheke Europe

sharewise wants to provide you with the best news and tools for Shop Apotheke Europe, so we directly link to the best financial data sources.

News

EQS-News: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
EQS-News: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
EQS-Adhoc: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-Adhoc: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
EQS-Adhoc: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
EQS-News: Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.
EQS-News: Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.
EQS-News: Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.
EQS-News: Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.
EQS-News: Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements.
EQS-News: Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements.
EQS-News: Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).
EQS-News: Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).
EQS-Adhoc: Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-Adhoc: Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024.
EQS-Adhoc: Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024.
EQS-News: Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.
EQS-News: Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.
EQS-News: Redcare Pharmacy: continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: Redcare Pharmacy: continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year.
EQS-News: Redcare Pharmacy: continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year.